COMMUNIQUÉS West-GlobeNewswire

OKYO Pharma Announces Purchase of Shares by Chief Medical Officer
22/07/2026
LONDON and NEW YORK, July 22, 2026 (GLOBE NEWSWIRE) -- OKYO Pharma Limited (Nasdaq: OKYO ), a clinical-stage biopharmaceutical company developing investigational therapies for the treatment of neuropathic corneal pain ( [...]
Akari Therapeutics CEO Explains Why Growing Industry Demand for Next-Generation ADC Payloads Positions the Company at the Center of a Major Oncology Opportunity
22/07/2026
Virtual Investor "What This Means" segment highlights strategic Whitehawk collaboration, accelerating industry validation of novel ADC payloads, and Akari's differentiated PH1 platform Watch the “What This Means” video [...]
Trinity Biotech Partners with Latch Medical to Advance Biosensor-Guided Precision Drug Delivery Solutions Using CGM+ Technology
22/07/2026
- Strategic collaboration and equity investment will combine Trinity Biotech's AI-native CGM+ wearable biosensor platform with Latch Medical's innovative intradermal drug delivery technology to develop next-generation [...]
Cannara annonce une offre publique de rachat dans le cours normal des activités
22/07/2026
MONTRÉAL, 22 juill. 2026 (GLOBE NEWSWIRE) -- Cannara Biotech Inc. (« Cannara », « la Société », « nous ») ( TSX : LOVE ) ( OTCQX : LOVFF ) ( FRA : 8CB0 ), producteur verticalement intégré de cannabis de qualité [...]
KC BioHub Awarded $38.1 Million to Advance Regional Biomanufacturing Growth
22/07/2026
Federally recognized Tech Hub positioned to unlock a total of $150 million in federal investment KANSAS CITY, Mo., July 22, 2026 (GLOBE NEWSWIRE) -- The KC BioHub, a program of BioNexus KC , with partners MRIGlobal and [...]
Tiziana Life Sciences Announces Purchase of Shares by Executive Chairman
22/07/2026
BOSTON, July 22, 2026 (GLOBE NEWSWIRE) -- Tiziana Life Sciences, Ltd. (Nasdaq: TLSA ) (“Tiziana” or the “Company”), a biotechnology company developing breakthrough immunomodulation therapies with its lead development [...]
Radiopharm Theranostics Announces Positive Phase 2b Trial Results of RAD 101 for Diagnosis of Brain Metastases
22/07/2026
RAD101 PET demonstrated 93% concordance with MRI across all evaluable lesions, meeting the trial's primary endpoint. 14 patients with available data from six-month follow-up and biopsy show preliminary 86% (12/14) [...]
Lungpacer Announces New Category III CPT® Codes for AeroPace® Diaphragm Neurostimulation Therapy
22/07/2026
New AMA Category III codes, effective July 1, 2026, support the development of future reimbursement pathways for temporary transvenous diaphragm neurostimulation EXTON, Pa., July 22, 2026 (GLOBE NEWSWIRE) -- Lungpacer [...]
Oncotelic Announces Peer-Reviewed Publication Validating Deciparticle™ Technology Supporting the Ongoing Clinical Development of Sapu003 (IV everolimus)
22/07/2026
AGOURA HILLS, Calif., July 22, 2026 (GLOBE NEWSWIRE) -- Oncotelic Therapeutics, Inc. (OTCQB: OTLC) and Sapu Nano today announced the publication of a comprehensive peer-reviewed study in Biomedicines describing the [...]
Trinity Biotech Plc Announces Plan to Implement ADS Ratio Change
22/07/2026
DUBLIN, July 22, 2026 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), (the “Company”) today announced that it plans to change the ratio of the American depositary shares (“ADSs”) representing its Class A [...]
Exubrion Therapeutics Promotes Gregory Taglialatela to Chief Commercial Officer
22/07/2026
ATLANTA, July 22, 2026 (GLOBE NEWSWIRE) -- Exubrion Therapeutics ® , the company behind Synovetin OA ® , has promoted Gregory Taglialatela, MBA, to Chief Commercial Officer, effective July 1, 2026. In his new role, [...]
Med X Holdings Announces Official Name Change to Dazed Inc. and New Ticker Symbol "DAZD"
22/07/2026
Welcome to Dazed Inc. Austin, Texas, July 22, 2026 (GLOBE NEWSWIRE) -- FOR IMMEDIATE RELEASE Med X Holdings Announces Official Name Change to Dazed Inc. and New Ticker Symbol "DAZD" AUSTIN, Texas – July 21, 2026 – Med X [...]
Radiopharm Theranostics Achieves Confirmed Durable Partial Response in Ongoing Phase 1 Trial of RAD204 in Patients with Advanced Solid Tumors Post-Immunotherapy
22/07/2026
First RECIST-confirmed durable Partial Response at current highest dose level #3 (90mCi) with the patient remaining progression free beyond seven months Second patient dosed remains progression free on treatment with [...]
Monopar Initiates Rolling NDA Submission for ALXN1840 in Wilson Disease
22/07/2026
WILMETTE, Ill., July 22, 2026 (GLOBE NEWSWIRE) -- Monopar Therapeutics Inc. (“Monopar” or the “Company”) (Nasdaq: MNPR), a clinical-stage biopharmaceutical company developing innovative treatments for patients with [...]
LB Pharmaceuticals Announces Accelerated Timing of Topline Results from the Phase 3 NOVA-2 Trial of LB-102 in Schizophrenia
22/07/2026
NEW YORK, July 22, 2026 (GLOBE NEWSWIRE) -- LB Pharmaceuticals Inc (“LB Pharmaceuticals” or the “Company”) (Nasdaq: LBRX), a neuromedicines company dedicated to developing and commercializing high-impact therapies that [...]
Traferox Technologies Receives FDA Premarket Approval for the TorEx Lung Perfusion System
22/07/2026
MISSISSAUGA, Ontario, July 22, 2026 (GLOBE NEWSWIRE) -- Traferox Technologies, Inc. today announced that the U.S. Food and Drug Administration (FDA) has granted Premarket Approval (PMA) for the TorEx ® Lung Perfusion [...]
Unnatural Products Appoints Finance Leader Neera Ravindran, M.D., M.B.A., as Chief Financial Officer
22/07/2026
SANTA CRUZ, Calif., July 22, 2026 (GLOBE NEWSWIRE) -- Unnatural Products, Inc. (UNP), a biotech developing orally-delivered macrocyclic peptides to address previously undruggable targets, today announced the appointment [...]
Bluesight and Pfizer Partner to Provide Source-Tagged RFID Medications to Hospital Pharmacies
22/07/2026
ALEXANDRIA, Va., July 22, 2026 (GLOBE NEWSWIRE) -- Pfizer’s SmartDose medications arrive pre-tagged and pre-associated for use with KitCheck, reducing manual tagging labor as part of RFID inventory management workflows [...]
New Analysis of Over 50 Studies Showed that All the Non-Prescription CBD Products Researched Fell Short of Therapeutic Efficacy — Reinforcing the Case for Artelo's Optimized ART12.11 CBD Composition
22/07/2026
Review Article Now Published in the British Journal of Clinical Pharmacology Finds Widely Sold Non-Prescription CBD Products at Doses Administered Failed to Provide Adequate Exposure for Positive Biological Effect [...]

Pages